Alpha 2.0
Login Register
» Authors » E Vijaya Bharathi

E Vijaya Bharathi

Explore the profile of E Vijaya Bharathi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 95
Followers 0
Related Specialties
Chemistry
Biochemistry
Pharmacology
Top 10 Co-Authors
Ahmed Kamal
M Janaki Ramaiah
S N C V L Pushpavalli
D Dastagiri
J Surendranadha Reddy
Manika Pal-Bhadra
Subrata Sen
Aarti Juvekar
A Viswanath
Surekha Zingde
Published In
Bioorg Med Chem
Bioorg Med Chem Lett
Eur J Med Chem
J Med Chem
ChemMedChem
Affiliations
Soon will be listed here.
Recent Articles
1.
Eight months of integrated yoga, hydrotherapy and acupuncture on serum IgE levels and symptoms severity of a patient with chronic allergic rhinosinusitis: A case report
Umadevi K, Vijaya Bharathi E, Mooventhan A, Nivethitha L
J Bodyw Mov Ther . 2024 Jun; 39:541-543. PMID: 38876682
A 27-year-old man with Allergic rhino sinusitis presented to our hospital in July 2020 with complaints of continuous sneezing, coughing while rising from bed for half an hour, and the...
2.
Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2)
Reddy M, Akula B, Jatiani S, Vasquez-Del Carpio R, Billa V, Mallireddigari M, et al.
Bioorg Med Chem . 2016 Jan; 24(4):521-44. PMID: 26762835
Several families of protein kinases have been shown to play a critical role in the regulation of cell cycle progression, particularly progression through mitosis. These kinase families include the Aurora...
3.
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5)
Reddy M, Akula B, Cosenza S, Athuluridivakar S, Mallireddigari M, Pallela V, et al.
J Med Chem . 2014 Jan; 57(3):578-99. PMID: 24417566
The success of imatinib, a BCR-ABL inhibitor for the treatment of chronic myelogenous leukemia, has created a great impetus for the development of additional kinase inhibitors as therapeutic agents. However,...
4.
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents
Reddy M, Mallireddigari M, Pallela V, Cosenza S, Billa V, Akula B, et al.
J Med Chem . 2013 Jun; 56(13):5562-86. PMID: 23750455
A series of novel (E)-N-aryl-2-arylethenesulfonamides (6) were synthesized and evaluated for their anticancer activity. Some of the compounds in this series showed potent cytotoxicity against a wide spectrum of cancer...
5.
Synthesis and biological evaluation of diaryl ether linked DC-81 conjugates as potential antitumor agents
Kamal A, Viswanath A, Ramaiah M, Murty J, Sultana F, Vijaya Bharathi E, et al.
Anticancer Agents Med Chem . 2013 Feb; 13(10):1590-600. PMID: 23438825
A series of new diaryl ether linked pyrrolobenzodiazepine (PBD) conjugates (4a-i, 5a-i and 6a-f) was synthesized and evaluated for their anticancer activity against a panel of 11 human cancer cell...
6.
Synthesis and apoptosis inducing ability of new anilino substituted pyrimidine sulfonamides as potential anticancer agents
Kamal A, Dastagiri D, Ramaiah M, Reddy J, Vijaya Bharathi E, Reddy M, et al.
Eur J Med Chem . 2011 Oct; 46(12):5817-24. PMID: 22000207
A series of anilino substituted pyrimidine sulfonamides were prepared and evaluated for their anticancer activity. These sulfonamides showed promising activity with IC(50) values ranging from 5.6 to 12.3 μM. The...
7.
Synthesis and biological evaluation of estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates as potential anticancer agents
Kamal A, Reddy M, Ramaiah M, Rajender , Reddy J, Srikanth Y, et al.
Bioorg Med Chem . 2011 Apr; 19(8):2565-81. PMID: 21459581
A series of new estradiol linked pyrrolo[2,1-c][1,4]benzodiazepine (E(2)-PBD) conjugates (3a-f, 4a-f and 5a-f) with different linker architectures including a triazole moiety have been designed and synthesized. All the 18 compounds...
8.
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents
Kamal A, Vijaya Bharathi E, Reddy J, Ramaiah M, Dastagiri D, Reddy M, et al.
Eur J Med Chem . 2011 Jan; 46(2):691-703. PMID: 21194809
A series of new 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydro quinazolinone hybrids with different linker architectures have been designed and synthesized. These compounds have been evaluated for their anticancer activity. One of...
9.
Synthesis of imidazothiazole-chalcone derivatives as anticancer and apoptosis inducing agents
Kamal A, Dastagiri D, Ramaiah M, Reddy J, Vijaya Bharathi E, Srinivas C, et al.
ChemMedChem . 2010 Sep; 5(11):1937-47. PMID: 20836120
A new class of imidazo[2,1-b]thiazole chalcone derivatives were synthesized and evaluated for their anticancer activity. These chalcone derivatives show promising activity, with log GI(50) values ranging from -7.51 to -4.00....
10.
Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole-pyrrolobenzodiazepine conjugates
Kamal A, Dastagiri D, Ramaiah M, Vijaya Bharathi E, Reddy J, Balakishan G, et al.
Bioorg Med Chem . 2010 Aug; 18(18):6666-77. PMID: 20732817
A series of 2,5-diaryloxadiazole linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates have been prepared and evaluated for their anticancer activity. These conjugates have shown promising activity with GI50 values ranging from <0.1 to 0.29...